What are the open and close dates of the Asston Pharmaceuticals IPO ?

Asston Pharmaceuticals IPO will be open between 2025-07-09 and 2025-07-11.

What is the allotment date for the Asston Pharmaceuticals IPO ?

Asston Pharmaceuticals IPO allotment date is 2025-07-15. For Asston Pharmaceuticals IPO allotment status check, you can visit the website of the registrar of the IPO.

Who is the registrar of Asston Pharmaceuticals IPO ?

For Asston Pharmaceuticals IPO, the IPO registrar is Maashitla Securities Private Limited. You can check Asston Pharmaceuticals IPO allotment status on the website of the registrar.

Where is the Asston Pharmaceuticals IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.

When will Asston Pharmaceuticals IPO shares be credited to your demat account?

The Asston Pharmaceuticals IPO shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.

What is the lot size and minimum order quantity of the Asston Pharmaceuticals IPO ?

The Asston Pharmaceuticals IPO lot size is 1000 and minimum order quantity is 2000.

What is the price band for the Asston Pharmaceuticals IPO ?

Asston Pharmaceuticals IPO has set the price band for its IPO at 123 per equity share with a face value of 10.

Home
/
IPO

180.30x

subscribed

Asston Pharmaceuticals IPO

Pharmaceuticals & Drugs

listed

₹2.30LMin. investment

Pre-apply
8 Jul
Bid start
9 Jul
Bid end
11 Jul
Allotment
14 Jul
Release of funds
15 Jul
Demat transfer
15 Jul
Listing
16 Jul

Asston Pharmaceuticals Limited IPO Details

Issue size

₹27Cr

IPO type

SME

Market Cap

₹104.7CrLower than sector avg

Price range

₹115 – ₹123

Listing ExchangeBSE

RevenueApr 2024 - Mar 2025

₹25.04CrLower than sector avg

Lot size

1000 shares

Draft Red Herring Prospectus

Read

Growth rate3Y CAGR

95.67%

SectorPharmaceuticals & Drugs

Price range₹115 – ₹123

IPO type

SME

Lot size1000 shares

Issue size₹27Cr

Draft Red Herring Prospectus

Read

Market Cap

₹104.7CrLower than sector avg

RevenueApr 2024 - Mar 2025

₹25.04CrLower than sector avg

Growth rate3Y CAGR

95.67%

Checklist

Quality analysis

Revenue growth

Company valuation

Earnings expansion

Risk analysis

Debt to Equity ratio

Promoter holdings

Shares pledged

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector

Sun Pharmaceutical Industries Ltd

Divi's Laboratories Ltd

Torrent Pharmaceuticals Ltd

Revenue

Higher revenue means strong sales and good market demand

This IPO

₹25.04Cr

This sector

₹1,331.47Cr

Compare with companies

PAT

Higher PAT means strong profitability and efficient cost management

This IPO

₹4.33Cr

This sector

₹193.4Cr

Compare with companies

Market cap

Higher market cap means strong confidence but may suggest overvaluation

This IPO

₹104.7Cr

This sector

₹10,914.84Cr

Compare with companies

P/E ratio

Lower ratio usually means stock is undervalued

This IPO

17.83

This sector

60.87

Compare with companies

D/E ratio

Lower ratio usually means fewer liabilities

This IPO

0.65

This sector

0.43

Compare with companies

Objectives

Working capital

47.10%

General corporate purposes

27.40%

Capital expenditure

21.70%

Repayment of loans

3.60%

About Asston Pharmaceuticals Limited

Incorporated in 2019, Asston Pharmaceuticals manufactures and exports pharmaceutical formulations and nutraceutical products for domestic and African markets. It operates through export sales, contract manufacturing/license sales, and domestic sales. The company’s Ambernath facility has a capacity of 8-9 crore tablets/month (currently 5-6 crore), 37.5 KL/month syrup, and 30-40 lakh sachets/month. It has five WHO-GMP-certified contract manufacturers under 5-year agreements and holds 150+ trademarks. Asston has 147 product registrations in African markets (Sierra Leone, Mali, Liberia, Ghana) and 10 filed in Cambodia, covering tablets, syrups, capsules, sachets, ophthalmic products, and creams. As of May 31, 2025, its order book stands at $4.75 million (₹40.86 crore) from 12 customers.

Asston Pharmaceuticals IPO Subscription Status

Date	QIB	NII	Retail	Total
09-Jul-25	3.51 times (X)	0.66 times (X)	1.22 times (X)	1.75 times (X)
10-Jul-25	4.47X	19.32X	16.66X	13.77X
11-Jul-25	85.76X	328.69X	170.1X	180.3X

Frequently asked questions

How to invest in the Asston Pharmaceuticals IPO ?

Investors can apply for the Asston Pharmaceuticals IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Asston Pharmaceuticals IPO ?

The issue size of the Asston Pharmaceuticals IPO is 27 Cr.

What is 'pre-apply' for Asston Pharmaceuticals IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Asston Pharmaceuticals IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.